Business
Why the ResApp (ASX:RAP) share price is edging higher
ResApp Health Ltd (ASX: RAP) shares are edging higher today after the company updated the market on its recent meeting with the United States Food and Drug Administration (FDA) for SleepCheck. In the minutes after market open, the ResApp share price reached an intra-day high of 9.3 cents but have partially retreated. At the time of writing, the ResApp share price is trading 2.22% higher at 9.2 cents.
What’s driving the ResApp share price?
The ResApp share price is on the move today after the company advised it has received a clear path to gain regulatory approval for its SleepCheck app to be used in the United States.
ResApp will pursue a 510(k) regulatory pathway for SleepCheck as a prescription only device. The 510(k) approach…
-
Noosa News19 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News23 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General18 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News18 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland